Vaccination against periodontitis: The saga continues

Expert Review of Vaccines

Volumn 6, Issue 4, 2007, Pages 579-590

  Dileep Sharma, C G ^a,b   Shiva Prasad, B M ^c   Karthikeyan, Bangalore Varadhan ^d  

^a KGF College of Dental Sciences ^*  (India)

^b KGF College of Dental Sciences and Hospital   (India)

^c Rajarajeshwari Dental College and Hospital   (India)

^d Al Badar Dental College   (India)

Author keywords

Immunization; Periodontal disease; Prevention; Vaccination

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL POLYSACCHARIDE; BACTERIAL VACCINE; BACTERIAL VECTOR; CAPSULAR POLYSACCHARIDE; CELL ENVELOPE ANTIGEN; CELL WALL ANTIGEN; CHOLERA TOXIN; CYSTEINE PROTEINASE; DRUG CARRIER; FIMBRIA PROTEIN; GINGIPAIN R; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 61BG13; MONOCLONAL ANTIBODY HAB OMP1; MONOCLONAL ANTIBODY HEMAGGLUTININ DOMAIN; MYCOBACTERIUM VACCAE VACCINE; PG32 ANTIGEN; PG33 ANTIGEN; PLANTIBODY; PORPHYPAIN 2; PORPHYROMONAS GINGIVALIS VACCINE; RABBIT ANTISERUM; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; BACTERIUM ADHERENCE; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DNA HYBRIDIZATION; DRUG FORMULATION; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; FIMBRIA; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; IMMUNOTHERAPY; IN VITRO STUDY; MEDICAL RESEARCH; NONHUMAN; PATHOGENESIS; PERIODONTITIS; PRIORITY JOURNAL; PROPHYLAXIS; RADIODIAGNOSIS; REVIEW; VACCINATION;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADHESINS, BACTERIAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; BACTERIAL CAPSULES; BACTERIAL VACCINES; CYSTEINE ENDOPEPTIDASES; DENTAL PLAQUE; FIMBRIAE PROTEINS; HUMANS; IMMUNIZATION, PASSIVE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; VACCINATION; VACCINES, SYNTHETIC;

EID: 34548039450     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.6.4.579     Document Type: Review

References (89)

1. Playfair J. Vaccination. In: Immunology. Roitt I, Brostoff J, Male D (Eds). Mosby, London, UK, 19.1-19.10 (1998).
2. Loesche WJ. Chemotherapy of dental plaque infections. Oral Sci. Rev. 9, 65-107 (1976).
3. Loesche WJ. Clinical and microbiological agents of chemotherapeutic gents used according to specific plaque hypothesis. J. Dent. Res. 58(12), 2404-2412 (1979).
4. Theilade E. The non-specific theory in microbial etiology of inflammatory periodontal disease. J. Clin. Periodontol. 13(10), 905-911 (1986).
5. Nãrskov-Lauritsen M, Kilian M. Reclassification of Actinobacillus actinomycetemcomitans, Haemophilus aphrophilus, Haemophilus paraphrophilus and Haemophilus segnis as Aggregatibacter actinomycetemcomitans gen. nov., comb. nov., Aggregatibacter aphrophilus comb. nov. and Aggregatibacter segnis comb. nov., and emended description of Aggregatibacter aphrophilus to include V factor-dependent and V factor-independent isolates. Int. J. Syst. Evol. Microbiol. 56(9) 2135-2146 (2006).
6. Moritz AJ, Cappelli D, Lantz MS, Holt SC, Ebersole JL. Immunization with Porphyromonas gingivalis cysteine protease: effects on experimental gingivitis and ligature induced periodontitis in Macaca fascicularis. J. Periodontol. 69(6), 686-697 (1998).
7. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25(2), 134-144 (1998).
8. Slots J. Systemic antibiotics in periodontics. J. Periodontol. 75(11), 1553-1565 (2004).
9. Parra B, Slots J. Detection of human viruses in periodontal pockets using polymerase chain reaction. Oral Microbiol. Immunol. 11(5), 289-293 (1996).
10. Contreras A, Umeda M, Chen C, Bakker I, Morrison LJ, Slots J. Relationship between herpesviruses and adult periodontitis and periodontopathic bacteria. J. Periodontol. 70(5), 478-484 (1999).
11. Kubar A, Saygun I, Yapar M, Ozdemir A, Slots J. Real-time PCR quantification of cytomegalovirus in aggressive periodontitis lesions using TaqMan technology. J. Periodontal Res. 39(2), 81-86 (2004).
12. Ling LJ, Ho CC, Wu CY, Chen YT, Hung SL. Association between human herpesviruses and the severity of periodontitis. J. Periodontol. 75(11), 1479-1485 (2004).
13. Loubinoux J, Bisson-Boutelliez C, Miller N, Le Faou AE. Isolation of the provisionally named Desulfovibrio fairfieldensis from human periodontal pockets. Oral Microbiol. Immunol. 17(5), 321-323 (2002).
14. Lepp PW, Brinig MM, Ouverney CC, Palm K, Armitage GC, Relman DA. Methanogenic archaea and human periodontal disease. Proc. Natl Acad. Sci. USA 101(16), 6176-6181 (2004).
15. Dzink JL, Socransky SS, Haffajee AD. The predominant cultivable microbiota of active and inactive lesions of destructive periodontal disease. J. Clin. Periodontol. 15(5), 316-323 (1988).
16. Sundqvist G. Pathogenicity and virulence of black-pigmented Gram-negative anaerobes. FEMS Immunol. Med. Microbiol. 6(2-3), 125-137 (1993).
17. Persson GR, Engel D, Whitney C, Darveau R, Weinberg A, Brunsvold M. Immunization against Porphyromonas gingivalis inhibits progression of experimental periodontitis in nonhuman primates. Infect. Immun. 62(3), 1026-1031 (1994).
18. Houston LS, Lukehart SA, Persson GR, Page RC. Function of anti-Porphyromonas gingivalis immunoglobulin classes in immunized Macaca fascicularis. Oral Microbiol. Immunol. 14(2), 86-91 (1999).
19. Page RC. Vaccination and periodontitis: myth or reality. J. Int. Acad. Periodontol. 2(2), 31-43 (2000).
20. Gibson FC, Gonzalez DA, Wong J, Genco CA. Porphyromonas gingivalis specific immunoglobulin G prevents Porphyromonas gingivalis elicited oral bone loss in a murine model. Infect. Immun. 72(4), 2408-2411 (2004).
21. Travis J, Pike R, Imamura T, Potempa J. Porphyromonas gingivalis proteinases as virulence factors in the development of periodontitis. J. Periodontal Res. 32(1 Pt 2), 120-125 (1997).
22. Kadowaki T, Yoneda M, Okamoto K, Maeda K, Yamamoto K. Purification and characterization of a novel arginine-specific cysteine protease (argingipain) involved in the pathogenesis of periodontal disease from the culture supernatant of Porphyromonas gingivalis. J. Biol. Chem. 269(33), 21371-21378 (1994).
23. Imamura T. The role of gingipains in the pathogenesis of periodontal disease. J. Periodontol. 74(1), 111-118 (2003).
24. Discipio RG, Daffern PJ, Kawahara M, Pike R, Travis J, Hugli TE. Activation of complement component C5 by cysteine proteases from Porphyromonas gingivalis. Prior oxidation of C5 augments proteinase digestion of C5. Immunology 87(4), 660-667 (1996).
25. Gibson FC, Genco CA. Prevention of Porphyromonas gingivalis induced oral bone loss following immunization with gingipain R1. Infect. Immun. 69(12), 7959-7963 (2001).
26. Rajapakse PS, O'Brien-Simpson NM, Slakeski N, Hoffmann B, Reynolds EC. Immunization with the RgpA-Kgp proteinase-adhesin complexes of Porphyromonas gingivalis protects against periodontal bone loss in the rat periodontitis model. Infect. Immun. 70(5), 2480-2486 (2002).
27. De Carlo AA, Huang Y, Collyer CA, Langley DB, Katz J. Feasibility of an HA2 domain-based periodontitis vaccine. Infect. Immun. 71(1), 562-566 (2003).
28. Inagaki S, Ishihara K, Takahashi J, Yasaki Y, Yamada S, Okuda K. Antibody response of periodontitis patients to gingipains of Porphyromonas gingivalis. J. Periodontol. 74(10), 1432-1439 (2003).
29. Genco CA, Odusanya BM, Potempa J, Mikolajczyk-Pawlinska J, Travis J. A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice. Infect. Immun. 66(9), 4108-4114 (1998).
30. O'Brien-Simpson NM, Paolini RA, Reynolds EC. RgpA-Kgp peptide based immunogens provide protection against Porphyromonas gingivalis challenge in a murine lesion model. Infect. Immun. 68(7), 4055-4063 (2000).
31. Kuboniwa M, Amano A, Shizukuishi S, Nakagawa I, Hamada S. Specific antibodies to Porphyromonas gingivalis Lysgingipain by DNA vaccination inhibit bacterial binding to hemoglobin and protect mice from infection. Infect. Immun. 69(5), 2972-2979 (2001).
32. O'Brien-Simpson NM, Pathirana RD, Paolini RA et al. An immune response directed to proteinase and adhesin functional epitopes protects against Porphyromonas gingivalis-induced periodontal bone loss. J. Immunol. 175(6), 3980-3989 (2005).
33. Lamont RJ, Jenkinson HF. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol. Mol. Biol. Rev. 62(4), 1244-1263 (1998).
34. Hamada N, Sojar HT, Cho MI, Genco RJ. Isolation and characterization of a minor fimbria from Porphyromonas gingivalis. Infect. Immun. 64(11), 4788-4794 (1996).
35. Ogawa T, Yasuda K, Yamada K, Mori H, Ochiai K, Hasegawa M. Immunochemical characterization and epitope mapping of a novel fimbrial protein (Pg-II fimbria) of Porphyromonas gingivalis. FEMS Immunol. Med. Microbiol. 11(3), 247-255 (1995).
36. Evans RT, Klausen B, Sojar HT, Bedi GS, Sfintescu C, Ramamurthy NS. Immunization with Porphyromonas (Bacteroides) gingivalis fimbriae protects against periodontal destruction. Infect. Immun. 60(7), 2926-2935 (1992).
37. Baum BJ, O'Connell BC. The impact of gene therapy on dentistry. J. Am. Dent. Assoc. 126(2), 179-189 (1995).
38. Fan Q, Sim ST, Sojar H, Genco R, Page RC. Fimbriae of Porphyromonas gingivalis induce opsonic antibodies that significantly enhance phagocytosis and killing by human polymorphonuclear leukocytes. Oral Microbiol. Immunol. 16(3), 144-152 (2001).
39. Choi JI, Schifferle RE, Yoshimura F, Kim BW. Capsular polysaccharide-fimbrial protein conjugate vaccine protects against Porphyromonas gingivalis infection in SCID mice reconstituted with human peripheral blood lymphocytes. Infect. Immun. 66(1), 391-393 (1998).
40. Gonzalez D, Tzianabos AO, Genco CA, Gibson FC. Immunization with Porphyromonas gingivalis capsular polysaccharide prevents Porphyromonas gingivalis elicited oral bone loss in a murine model. Infect. Immun. 71(4), 2283-2287 (2003).
41. Takazoe I, Nakamura T, Okuda K. Colonization of the subgingival area by Bacteroides gingivalis. J. Dent. Res. 63(3), 422-426 (1984).
42. Slots J, Gibbons RJ. Attachment of Bacteroides melaninogenicus subspecies asaccharolyticus to oral surfaces and its possible role in colonization of the mouth and of periodontal pockets. Infect. Immun. 19(1), 254-264 (1978).
43. Mouton C, Bouchard D, Deslauriers M, Lamonde L. Immunochemical identification and preliminary characterization of a nonfimbrial hemagglutinating adhesin of Bacteroides gingivalis. Infect. Immun. 57(2), 566-573 (1989).
44. Ellen RP, Grove DA. Bacteroides gingivalis vesicles bind to and aggregate Actinomyces viscosus. Infect. Immun. 57(5), 1618-1620 (1989).
45. Gibbons RJ, Nygaard M. Interbacterial aggregation of plaque bacteria. Arch. Oral Biol. 15(12), 1397-1400 (1970).
46. Maeba S, Otake S, Namikoshi J, Shibata Y, Hayakawa M, Abiko Y, Yamamoto M. Transcutaneous immunization with a 40-kDa outer membrane protein of Porphyromonas gingivalis induces specific antibodies which inhibit co-aggregation by Porphyromonas gingivalis. Vaccine 23(19), 2513-2521 (2005).
47. Namikoshi Y, Otake S, Maeba S, Hayakawa M, Abiko Y, Yamamoto M. Specific antibodies induced by nasally administered 40-kDa outer membrane protein of Porphyromonas gingivalis inhibits co-aggregation activity of P. gingivalis. Vaccine 22(2), 250-256 (2003).
48. Saito S, Hiratsuka K, Hayakawa M, Takiguchi H, Abiko Y. Inhibition of a Porphyromonas gingivalis colonization factor between Actinomyces viscous ATCC19246 by monoclonal antibodies against recombinant 40-kDa outer membrane protein. Gen. Pharmacol. 28(5), 675-680 (1997).
49. Abiko Y, Ogura N, Matsuda U, Yanagi K, Takiguchi H. A human monoclonal antibody which inhibits the co-aggregation activity of Porphyromonas gingivalis. Infect. Immun. 65(9), 3966-3969 (1997).
50. Saito S, Hayakawa M, Takiguchi H, Abiko Y. Opsonophagocytic effect of antibody against recombinant conserved 40-kDa outer membrane protein of Porphyromonas gingivalis. J. Periodontol. 70(6), 610-617 (1999).
51. Ross BC, Czajkowski L, Hocking D et al. Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis. Vaccine 19(30), 4135-4142 (2001).
52. Ross BC, Czajkowski L, Vandenberg KL, Camuglia S, Woods J, Agius C. Characterization of two outer membrane protein antigens of Porphyromonas gingivalis that are protective in a murine lesion model. Oral Microbiol. Immunol. 19(1), 6-15 (2004).
53. Chu L, Bramanti TE, Ebersole JL, Holt SC. Hemolytic activity in the periodontopathogen Porphyromonas gingivalis kinetics of enzyme release and localization. Infect. Immun. 59(6), 1932-1940 (1991).
54. Okuda K, Kato T, Naito Y, Takazoe I, Kikuchi Y, Nakamura T. Protective efficacy of active and passive immunizations against experimental infection in ligated hamsters. J. Dent. Res. 67(5), 807-811 (1988).
55. Booth V, Ashley FP, Lehner T. Passive immunization with monoclonal antibodies against Porphyromonas gingivalis in patients with periodontitis. Infect. Immun. 64(2), 422-427 (1996).
56. Booth V, Lehner T. Characterization of the Porphyromonas gingivalis antigen recognized by a monoclonal antibody which prevents colonization by the organism. J. Periodontal Res. 32(1 Pt 1), 54-60 (1997).
57. Shibata Y, Kurihara K, Takiguchi H, Abiko Y. Construction of a functional ScFv antibody against a hemagglutinin from Porphyromonas gingivalis. Infect. Immun. 66(5), 2207-2312 (1998).
58. Hosogi Y, Hayakawa M, Abiko Y. Monoclonal antibody against Porphyromonas gingivalis hemagglutinin inhibits hemolytic activity. Eur. J. Oral Sci. 109(2), 109-113 (2001).
59. Kaizuka K, Hosogi Y, Hayakawa M, Shibata Y, Abiko Y. Human monoclonal antibody inhibits Porphyromonas gingivalis hemagglutinin activity. J. Periodontol. 74(1), 38-43 (2003).
60. Shibata Y, Hosogi Y, Hayakawa M, Hori N, Kamada M, Abiko Y. Construction of novel human monoclonal antibodies neutralizing Porphyromonas gingivalis hemagglutination activity using transgenic mice expressing human Ig loci. Vaccine 23(29), 3850-3856 (2005).
61. Zhang P, Yang QB, Balkovetz DF et al. Effectiveness of the B subunit of cholera toxin in potentiating immune responses to the recombinant hemagglutinin/adhesin domain of the gingipain Kgp from Porphyromonas gingivalis. Vaccine 23(39), 4734-4744 (2005).
62. Harano K, Yamanaka A, Okuda K. An antiserum to a synthetic fimbrial peptide of Actinobacillus actinomycetemcomitans blocked adhesion of the microorganism. FEMS Microbiol. Lett. 130(2-3), 279-285 (1995).
63. Takamatsu-Matsushita N, Yamaguchi N, Kawasaki M, Yamashita Y, Takehara T, Koga T. Immunogenicity of Actinobacillus actinomycetemcomitans serotype b-specific polysaccharide-protein conjugate. Oral Microbiol. Immunol. 11(4), 220-225 (1996).
64. Herminajeng E, Asmara W, Yuswanto, Barid I, Sosroseno W. Protective humoral immunity induced by surface associated material from Actinobacillus actinomycetemcomitans in mice. Microbes Infect. 3(12), 997-1003 (2001).
65. Tanner AC, Socransky SS, Goodson JM. Microbiota of periodontal pockets losing crestal alveolar bone. J. Periodontal Res. 19(3), 279-291 (1984).
66. Cox SE, Holt SC, Ebersole JL. Characteristics of systemic antibody responses of nonhuman primates to cell envelope and cell wall antigens from periodontal pathogens. Oral Microbiol. Immunol. 12(4), 204-211 (1997).
67. Giardino A, Ebersole JL, Holt SC. Characteristics of systemic antibody responses of nonhuman primates following active immunization with Porphyromonas gingivalis, Prevotella intermedia and Bacteroides fragilis. Oral Microbiol. Immunol. 11(2), 79-87 (1996).
68. Gemmell E, Bird PS, Ford PJ et al. Modulation of the antibody response by Porphyromonas gingivalis and Fusobacterium nucleatum in a mouse model. Oral Microbiol. Immunol. 19(4), 247-51 (2004).
69. Vasel D, Sims TJ, Bainbridge B, Houston L, Darveau R, Page RC. Shared antigens of Porphyromonas gingivalis and Bacteroides forsythus. Oral Microbiol. Immunol. 11(4), 226-235 (1996).
70. Lee JY, Yi NN, Kim US, Choi JS, Kim SJ, Choi JI. Porphyromonas gingivalis heat shock protein Vaccine reduces the alveolar bone loss induced by multiple periodontopathogenic bacteria. J. Periodontal Res. 41(1), 10-14 (2006).
71. Sharma A, Sojar HT, Hruby DE, Kuramitsu HK, Genco RJ. Secretion of Porphyromonas gingivalis fimbrillin polypeptides by recombinant Streptococcus gordonii. Biochem. Biophys. Res. Commun. 238(2), 313-316 (1997).
72. Sharma A, Honma K, Evans TR, Hruby DE. Oral immunization with recombinant Streptococcus gordonii expressing Porphyromonas gingivalis Fim A domains. Infect. Immun. 69(5), 2928-2934 (2001).
73. Kozarov E, Miyashita N, Burks J, Cerveny K. Expression and immunogenicity of hemagglutinin A from Porphyromonas gingivalis in an avirulent Salmonella enterica. Infect. Immun. 68(2), 732-739 (2000).
74. Katz J, Black KP, Michalek SM. Host response to recombinant hemagglutinin B of Porphyromonas gingivalis in an experiment rat model. Infect. Immun. 67(9), 4352-4359 (1999).
75. Nair SP, Meghji S, Reddi K, Poole S, Miller AD, Henderson B. Molecular chaperones stimulate bone resorption. Calcif. Tissue Int. 64(3), 214-218 (1999).
76. Castellino F, Boucher PE, Eichelberg K. Receptor-mediated uptake of antigen/heat shock protein complexes class 1 antigen presentation via two distinct processing pathways. J. Exp. Med. 191(11), 1957-1964 (2000).
77. Breivik T, Rook GA. Prevaccination with SRL172 (heat-killed Mycobacterium vaccae) inhibits experimental periodontal disease in wistar rats. Clin. Exp. Immunol. 120(3), 463-467 (2000).
78. Breivik T, Rook GA. Treatment with SRL172 (heat-killed Mycobacterium vaccae) inhibits progression of established experimental periodontal disease in wistar rats. J. Periodontal Res. 37(3), 210-214 (2002).
79. Breivik T, Rook GA. Oral treatment with SRP299 (killed Mycobacterium vaccae) inhibits experimental periodontal disease in wistar rats. J. Clin. Periodontol. 30(11), 931-936 (2003).
80. Dusek DM, Progulske-Fox A, Whitlock J, Brown TA. Isolation and characterization of a cloned Porphyromonas gingivalis hemagglutinin from an avirulent strain of Salmonella typhimurium. Infect. Immun. 61(3), 940-946 (1993).
81. Dusek DM, Progulske-Fox A, Brown TA. Systemic and mucosal immune responses in mice orally immunized with avirulent Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin. Infect. Immun. 62(5), 1652-1657 (1994).
82. Kohler JJ, Pathangey LB, Brown TA. Oral immunization with recombinant Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin: effect of boosting on mucosal, systemic and immunoglobulin G subclass response. Oral Microbiol. Immunol. 13(2), 81-88 (1998).
83. Yamashita K, Eastcott JW, Taubman MA, Smith DJ, Cox DS. Effect of adoptive transfer of cloned Actinobacillus actinomycetemcomitans-specific T helper cells on periodontal disease. Infect. Immun. 59(4), 1529-1534 (1991).
84. Roberts FA, Laura S, Lukehart SA, Mancl LA, Persson R, Page RC. Periodontitis vaccine decreases local prostaglandin E2 levels in a primate model. Infect. Immun. 72(2), 1166-1168 (2004).
85. Yang QB, Martin M, Michalek SM, Katz J. Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis. Infect. Immun. 70(7), 3557-3565 (2002).
86. Arntzen CJ. High-tech herbal medicine: plant-based vaccines. Nat. Biotechnol. 15(3), 221-222 (1997).
87. Ma JK, Hiatt A, Hein M et al. Generation and assembly of secretory antibodies in plants. Science 268(5211), 716-719 (1995).
88. Ma JK, Hikmat BY, Wycoff K et al. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat. Med. 4(5), 601-606 (1998).
89. Shin EA, Lee JY, Kim TG, Park YK, Langridge WH. Synthesis and assembly of an adjuvanted Porphyromonas gingivalis fimbrial antigen fusion protein in plants. Protein Expr. Purif. 47(1), 99-109 (2006).